Bio Medica Laboratories Limited (NSE:BMLL)

Market Cap	1.85B
Revenue (ttm)	430.90M +103.0%
Net Income	117.81M +1,900.1%
EPS	12.95 +1,918.4%
Shares Out	12.58M
PE Ratio	11.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Open	147.95
Previous Close	144.35
Day's Range	147.00 - 148.00
52-Week Range	101.50 - 162.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Bio Medica Laboratories

Bio Medica Laboratories Limited engages in manufacturing pharmaceutical parenteral formulations in India. It manufactures variety of products, comprising ethical drugs, generic drugs and over the-counter drugs in the form of injectables namely Liquid Injections and dry powder injections. It provides human injectables, export of injectables, veterinary injectables, contract manufacturing, quality assurance, and research and development services. The company caters to human and veterinary needs. The company was formerly known as Bio Medica Labora...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BMLL

Financial Performance

In fiscal year 2026, Bio Medica Laboratories's revenue was 430.90 million, an increase of 12.81% compared to the previous year's 381.95 million. Earnings were 117.81 million, an increase of 20.27%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 17, 2026

Data Sources Report a data error